BioCentury
ARTICLE | Clinical News

Axiron testosterone regulatory update

December 6, 2010 8:00 AM UTC

FDA approved an NDA from Acrux for Axiron testosterone as replacement therapy in men for conditions associated with a deficiency or absence of testosterone, including primary and hypogonadotropic hypo...